HK1152932A1 - 稠環化合物及其用途 - Google Patents

稠環化合物及其用途

Info

Publication number
HK1152932A1
HK1152932A1 HK11106909.4A HK11106909A HK1152932A1 HK 1152932 A1 HK1152932 A1 HK 1152932A1 HK 11106909 A HK11106909 A HK 11106909A HK 1152932 A1 HK1152932 A1 HK 1152932A1
Authority
HK
Hong Kong
Prior art keywords
fused ring
ring compounds
compounds
fused
ring
Prior art date
Application number
HK11106909.4A
Other languages
English (en)
Inventor
Tsuneo Yasuma
Nobuyuki Takakura
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of HK1152932A1 publication Critical patent/HK1152932A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
HK11106909.4A 2008-04-10 2011-07-05 稠環化合物及其用途 HK1152932A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008102691 2008-04-10
PCT/JP2009/057625 WO2009125873A1 (en) 2008-04-10 2009-04-09 Fused ring compounds and use thereof

Publications (1)

Publication Number Publication Date
HK1152932A1 true HK1152932A1 (zh) 2012-03-16

Family

ID=40671202

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11106909.4A HK1152932A1 (zh) 2008-04-10 2011-07-05 稠環化合物及其用途

Country Status (35)

Country Link
US (1) US8673942B2 (zh)
EP (1) EP2276760B1 (zh)
JP (1) JP5528348B2 (zh)
KR (1) KR20110002472A (zh)
CN (1) CN102056924B (zh)
AR (1) AR073609A1 (zh)
AU (1) AU2009234666B2 (zh)
BR (1) BRPI0910912A2 (zh)
CA (1) CA2720686A1 (zh)
CO (1) CO6321240A2 (zh)
CR (1) CR11730A (zh)
CY (1) CY1115247T1 (zh)
DK (1) DK2276760T3 (zh)
DO (1) DOP2010000301A (zh)
EA (1) EA019640B1 (zh)
EC (1) ECSP10010602A (zh)
ES (1) ES2476265T3 (zh)
GE (1) GEP20135846B (zh)
HK (1) HK1152932A1 (zh)
HR (1) HRP20140588T1 (zh)
IL (1) IL208463A (zh)
MA (1) MA32283B1 (zh)
ME (1) ME01887B (zh)
MX (1) MX2010011138A (zh)
MY (1) MY152475A (zh)
NZ (1) NZ588562A (zh)
PE (1) PE20100734A1 (zh)
PL (1) PL2276760T3 (zh)
PT (1) PT2276760E (zh)
RS (1) RS53378B (zh)
SI (1) SI2276760T1 (zh)
UA (1) UA104422C2 (zh)
UY (1) UY32131A (zh)
WO (1) WO2009125873A1 (zh)
ZA (1) ZA201007682B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2010076884A1 (ja) 2008-12-29 2012-06-21 武田薬品工業株式会社 新規縮合環化合物およびその用途
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US9719970B2 (en) 2012-11-30 2017-08-01 Waters Technologies Corporation Methods and apparatus for the analysis of vitamin D metabolites
US9453038B2 (en) 2012-12-17 2016-09-27 Merck Sharp & Dohme Corp. Glucokinase activator compounds, compositions containing such compounds, and methods of treatment

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992015301A1 (en) 1991-03-01 1992-09-17 H. Lundbeck A/S Treatment of hypertension and peripheral vascular diseases
US6506901B2 (en) 2000-07-17 2003-01-14 Wyeth Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine β-3 adrenergic receptor agonists
TWI280876B (en) 2002-06-05 2007-05-11 Inst Med Molecular Design Inc Therapeutic drug for diabetes
EP1532980A1 (en) 2003-11-24 2005-05-25 Novo Nordisk A/S N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
EP1853255A4 (en) 2005-02-22 2009-07-08 Gemin X Pharmaceuticals Canada METHODS FOR TREATING ARTHRITIS USING TRIHETEROCYCLIC COMPOUNDS
EP1873144B1 (en) * 2005-04-20 2014-07-23 Takeda Pharmaceutical Company Limited Fused heterocyclic compound
CA2623958C (en) 2005-09-30 2013-05-28 Banyu Pharmaceutical Co., Ltd. 2-heteroaryl-substituted indole derivative
MEP11809A (en) 2006-10-19 2011-12-20 Indole compound
RU2477282C2 (ru) 2007-08-17 2013-03-10 Эл Джи Лайф Сайенсиз Лтд. Соединения индола в качестве ингибиторов клеточного некроза
EP2220081A4 (en) * 2007-12-20 2011-08-24 Lg Life Sciences Ltd GLUCCOAINEACTIVATORS AND THESE PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE SUBSTANCES
US20100291533A1 (en) 2008-01-04 2010-11-18 Soon Ha Kim Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect
JPWO2010076884A1 (ja) 2008-12-29 2012-06-21 武田薬品工業株式会社 新規縮合環化合物およびその用途

Also Published As

Publication number Publication date
ZA201007682B (en) 2011-12-28
UY32131A (es) 2010-11-30
CA2720686A1 (en) 2009-10-15
EA201071180A1 (ru) 2011-04-29
CN102056924B (zh) 2014-05-21
ECSP10010602A (es) 2011-03-31
KR20110002472A (ko) 2011-01-07
CO6321240A2 (es) 2011-09-20
MY152475A (en) 2014-10-15
US8673942B2 (en) 2014-03-18
IL208463A0 (en) 2010-12-30
HRP20140588T1 (hr) 2014-08-01
AU2009234666A1 (en) 2009-10-15
MA32283B1 (fr) 2011-05-02
ME01887B (me) 2014-12-20
NZ588562A (en) 2012-07-27
BRPI0910912A2 (pt) 2015-08-11
RS53378B (en) 2014-10-31
PT2276760E (pt) 2014-05-28
JP2011516403A (ja) 2011-05-26
ES2476265T3 (es) 2014-07-14
CR11730A (es) 2010-12-08
AR073609A1 (es) 2010-11-17
IL208463A (en) 2015-07-30
US20110098297A1 (en) 2011-04-28
GEP20135846B (en) 2013-06-10
DOP2010000301A (es) 2010-12-31
EP2276760B1 (en) 2014-04-09
JP5528348B2 (ja) 2014-06-25
SI2276760T1 (sl) 2014-05-30
CY1115247T1 (el) 2017-01-04
EP2276760A1 (en) 2011-01-26
UA104422C2 (uk) 2014-02-10
EA019640B1 (ru) 2014-05-30
AU2009234666B2 (en) 2014-02-20
CN102056924A (zh) 2011-05-11
WO2009125873A1 (en) 2009-10-15
DK2276760T3 (da) 2014-05-26
MX2010011138A (es) 2010-11-12
PL2276760T3 (pl) 2014-09-30
PE20100734A1 (es) 2010-11-18

Similar Documents

Publication Publication Date Title
EP2424856A4 (en) CONDENSED HETEROCYCLIC COMPOUND AND ITS USE
HK1162505A1 (en) Fused ring compound and use thereof
EP2440058A4 (en) FOUNDED HETEROCYCLIC COMPOUNDS AND USES THEREOF
EP2471789A4 (en) FUSED HETEROCYCLIC CORE DERIVATIVE AND USE THEREOF
HK1152932A1 (zh) 稠環化合物及其用途
GB0818241D0 (en) Compounds and their use
HUE059796T2 (hu) PSMA-t célzó vegyületek és alkalmazásaik
IL208081A0 (en) Amido - thiophene compounds and their use
ZA201007395B (en) Aryl-quinolyl compounds and their use
PL2344449T3 (pl) Związki arylo-fenylo-sulfonamido-cykloalkilowe i ich zastosowanie
EP2471791A4 (en) CONDENSED HETEROCYCLE DERIVATIVE AND USE THEREOF
EP2379505A4 (en) MODIFIED CHLOROQUINE WITH SINGLE RING UNIT OR CONDENSED RING UNIT
EP2388320A4 (en) ANTI-HS6ST2 ANTIBODIES AND USE THEREOF
GB0902173D0 (en) Compounds and their use
EP2371826A4 (en) NEW CONNECTION WITH CONDENSED RINGS AND ITS USE
EP2350086A4 (en) CONDENSED DIIMIDAZODIAZEPINE COMPOUNDS AND METHOD FOR THEIR USE AND MANUFACTURE
EP2170874A4 (en) NEW COMPOUNDS AND THEIR USE
EP2471793A4 (en) FUSED HETEROCYCLIC CORE DERIVATIVE AND USE THEREOF
GB0801319D0 (en) Compounds and their use
ZA201201795B (en) Fused heterocyclic ring derivative and use thereof
GB0817414D0 (en) Sutassist-suture ring
GB0802194D0 (en) Compounds and their use
GB0813254D0 (en) Compounds and their use
GB0817897D0 (en) Compounds and their use
GB0902013D0 (en) Novel compounds and their use

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180409